In review: the life sciences regulatory regime in Sweden

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Sweden, including clinical trials and marketing authorisations.

Related Keywords

Sweden ,Helsinki ,Eteläuomen Läi ,Finland ,Swedish , ,Swedish Association Of The Pharmaceutical Industry ,European Commission ,Un Convention On Narcotic Drugs ,Registration Office ,World Medical Association Declaration Of Helsinki ,Swedish Ethical Review Authority ,European Union ,European Medicines Agency ,Information Examiner Committee ,Information Practices Committee ,Medicinal Product Act ,Medicinal Products Ordinance ,Medicinal Products Act ,Product Safety ,Animal Protection ,Swedish Board ,Medical Products ,Ethical Review Act ,Swedish Ethical Review ,World Medical Association ,Mitigate Risks ,First In Human Clinical Trials ,Investigational Medicinal Products ,European Database ,Medical Devices ,Act Containing Supplementary Provisions ,Ethical Review ,European Clinical Trials ,Patient Data ,Patient Data Act ,Medicinal Ordinance ,Member State ,Member States ,Medicinal Products ,Supplementary Protection Certificate ,Swedish Patent ,Marketing Practices Act ,Swedish Association ,Pharmaceutical Industry ,Ethical Rules ,Medicinal Products Trading Act ,Medicinal Products Trading ,European Economic Area ,Medical Devices Act ,Medical Devices Ordinance ,Product Safety Act ,Penal Law ,Narcotic Drugs ,Swedish Penal ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Ealthcare Amp Life Sciences ,